|
Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices – Budget Impact Analysis
The citation for this report is: Mauskopf JA, Sullivan SD, Annemans L, et al. Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices – Budget Impact Analysis.
Value in Health 2007;10;336-47
Task Force Chairs:
Jo Mauskopf PhD, RTI Health Solutions, RTI
International, Research Triangle Park, North Carolina, USA
Sean Sullivan PhD, RPh, MS, Professor and Director,
University of Washington, Pharmaceutical Outcomes Research and Policy
Program, Seattle, WA, USA
Leadership Group:
Lieven Annemans PhD, MSc, , Health Economist, Ghent
University and Senior Consultant Global Health Economic, HEDM and
IMS Health, Brussels, Belgium
Jaime Caro, MD, Scientific Director, Caro Research,
Concord, MA, USA
C. Daniel Mullins PhD, Professor and Chair of
Pharmaceutical Health Services Research, University of Maryland,
School of Pharmacy, Baltimore, MD, USA
Mark Nuijten PhD, MBA, MD, Researcher, Imta, Erasmus
University, Rotterdam, The Netherlands
Ewa Orlewska MD, PhD, Lecturer, Centre for
Pharmacoeconomics, Warsaw, Poland
Paul Trueman MA, BA, Director, York Health Economics
Consortium, Heslington, York, UK
John Watkins RPh MPH, Pharmacy Manager, Formulary
Development, Premera Blue Cross, Bothell, WA, USA |
